Video

How Renal Function and Comorbidities Affect Dosing for NOACs

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient’s renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.

Related Videos
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Muscular dystrophy. A group of diseases that cause progressive weakness and loss of muscle mass. abnormal genes interfere with the production of proteins needed to form healthy muscle - Image credit: Thipphaphone | stock.adobe.com
January 23rd 2025

DYNE-101 Receives FDA Fast Track Designation to Treat Myotonic Dystrophy

Kennedy Ferruggia, Assistant Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Woman experiencing depression -- Image credit: nenetus | stock.adobe.com
January 23rd 2025

Navacaprant Did Not Show Statistically Significant Improvements When Treating Patients With Major Depressive Disorder

Gillian McGovern, Associate Editor
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
FDA headquarters -- Image credit: Tada Images | stock.adobe.com
Published: January 23rd 2025 | Updated: January 23rd 2025

FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus

Gillian McGovern, Associate Editor
Doctor or physician recommend pills medical prescription to male Patient hospital and medicine concept - Image credit: joyfotoliakid | stock.adobe.com
January 23rd 2025

Encourage Patient Accountability for Optimal Medication Safety

Kathleen Kenny, PharmD, RPh